215,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 1-2 Wochen
  • Gebundenes Buch

This book offers tangible insights into the strategies deployed by well-known, high-profile organizations involved in anticipating the various societal and policy implications of nanotechnology and synthetic biology. It focuses predominantly on an examination of the practices adopted by the often-cited and uniquely positioned Project on Emerging Nanotechnologies in the United States, as well as being informed by comparisons with a range of institutions also interested in embedding forward-looking perspectives in their respective area of innovation. The book lays out one of the first actionable…mehr

Produktbeschreibung
This book offers tangible insights into the strategies deployed by well-known, high-profile organizations involved in anticipating the various societal and policy implications of nanotechnology and synthetic biology. It focuses predominantly on an examination of the practices adopted by the often-cited and uniquely positioned Project on Emerging Nanotechnologies in the United States, as well as being informed by comparisons with a range of institutions also interested in embedding forward-looking perspectives in their respective area of innovation. The book lays out one of the first actionable roadmaps that other interested stakeholders can follow when working toward institutionalizing anticipatory governance practices throughout the policymaking process.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Evan S. Michelson is a Program Director at the Alfred P. Sloan Foundation, USA